Treatment failure; rehospitalization or adjustment of antimicrobial treatment (or both) in number of episodes · children with cancer
Early discharge showed no clear difference in treatment failure; rehospitalization or adjustment of antimicrobial… compared with non‐early discharge (low certainty).
1 finding from 1 review
RR 0.91 [0.24, 3.5]
Studies not reported
Low
Treatment failure; death · children with cancer
Very early discharge may leads to lower treatment failure; death compared with early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Costs · children with cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of total antimicrobial treatment · children with cancer
Very early discharge may leads to lower duration of total antimicrobial treatment compared with early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Duration of intravenous antimicrobial treatment · children with cancer
Very early discharge may leads to lower duration of intravenous antimicrobial treatment compared with early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Duration of oral antimicrobial treatment · children with cancer
Very early discharge may leads to lower duration of oral antimicrobial treatment compared with early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Quality of life · children with cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment failure; death · children with cancer
Early discharge may leads to lower treatment failure; death compared with non‐early discharge (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Costs · children with cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Duration of total antimicrobial treatment · children with cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Duration of intravenous antimicrobial treatment · children with cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Duration of oral antimicrobial treatment · children with cancer
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Quality of life · children with cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment failure; rehospitalization or adjustment of antimicrobial treatment (or both) in number of episodes · children with cancer
Very early discharge showed no clear difference in treatment failure; rehospitalization or adjustment of antimicrobial… compared with early discharge (low certainty).
1 finding from 1 review
RR 0.54 [0.15, 1.89]
Studies not reported
Low
Treatment failure; rehospitalization or adjustment of antimicrobial treatment (or both), only first episode in number of participants · children with cancer
Very early discharge showed no clear difference in treatment failure; rehospitalization or adjustment of antimicrobial… compared with early discharge (low certainty).
1 finding from 1 review
RR 0.32 [0.07, 1.4]
Studies not reported
Low
Number of participants with at least 1 bleeding episode · People with chronic bone marrow failure
Thrombopoietin mimetic showed no clear difference in number of participants with at least one bleeding episode compared with placebo (low certainty).
1 finding from 1 review
Number of participants with severe or life‐threatening bleeding · People with chronic bone marrow failure
Thrombopoietin mimetic showed no clear difference in number of participants with at least one severe or life‐threatening… compared with placebo (low certainty).
1 finding from 1 review
All‐cause mortality · People with chronic bone marrow failure
It is very uncertain whether thrombopoietin mimetic changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
Proportion of patients receiving platelets · People with chronic bone marrow failure
Thrombopoietin mimetic probably leads to lower proportion of participants receiving a platelet transfusion compared with placebo (moderate certainty).
1 finding from 1 review
Blood transfusion reaction · People with chronic bone marrow failure
1 finding from 1 review